baber/WOPTO huggingface dataset:
Patent AU-779358-B2 (AU)
Title: Filter apparatus for ostium of left atrial appendage
Inventor: TASSEL ROBERT A VAN
IPC: A61F2/01
Filed: 2000-10-26
Granted: 2005-01-20
Abstract: Apparatus for permanent placement across an ostium of a left atrial appendage in a patient, which includes a filtering membrane configured to extend across the ostium of the left atrial appendage. The filtering membrane has a permeable structure which allows blood to flow through but substantially inhibits thrombus from passing therethrough. The apparatus also includes a support structure attached to the filtering membrane which retains the filtering membrane in position across the ostium of the left atrial appendage by permanently engaging a portion of the interior wall of the left atrial appendage. The support structure may be radially expandable from a first configuration to a second configuration which engages the ostium or the interior wall of the left atrial appendage. The filtering membrane may define an opening therethrough that is configured to expand from a first size which inhibits the passage of thrombus therethrough to a second size which allows an interventional device, e.g., an expansion balloon, to pass therethrough, and wherein the opening is resiliently biased towards the first size.
Patent AU-766256-B2 (AU)
Title: New compounds for the treatment of cancer
Inventor: STRELCHENOK OLEG
IPC: A61P35/00
Filed: 1999-12-28
Granted: 2003-10-09
Abstract: It is shown that the potency of anti-cancer drugs, here exemplified by doxorubicin, can be increased by the use of polyunsaturated fatty acid amides and in particular specific combinations of such compounds, forming complexes with doxorubicin. Further, a modified form of doxorubicin is presented.
Patent AU-754764-B2 (AU)
Title: Prevention of immunoreactivity by depleting or inhibiting antigen presenting cells
Inventor: SHLOMCHIK WARREN D
IPC: A61K39/00
Filed: 1998-11-12
Granted: 2002-11-21
Abstract: The invention includes compositions and methods for depleting antigen presenting cells, or for impairing the biological function of antigen presenting cells, which compositions are useful for treatment of graft versus host disease and other immune diseases.
Patent AU-651451-B2 (AU)
Title: An application program interface
Inventor: BERGLER FRANK
IPC: H04Q11/04
Filed: 1992-05-18
Granted: 1994-07-21
Abstract: It is the object to implement an application program interface for integrated-services networks so that application programs can be generated independently of network protocols (layer 1, 2; 1TR6, VN2) and independently of the respective implementation of features. The application program interface receives an independent service program module for each network service (telephony, telefax, packet data, teletex ...) each having a communication record representing function sequences and oriented by standards (CCITT, ETSI ...). <IMAGE>
Patent AU-758377-B2 (AU)
Title: Passive remote programmer for induction type RFID readers
Inventor: CASDEN MARTIN S
IPC: H04M3/00
Filed: 1999-12-10
Granted: 2003-03-20
Abstract: A hand held passive remote programmer for Radio Frequency Identification readers has a keyboard for turning on any one of several RFID transponder tags in the programmer. Each transponder of the programmer is recognizable by the RFID reader as a program instruction which modifies the operation of the reader, rather than one of a second population of transponder tags which are recognized simply by proximity to the reader, such as tags provided in key cards. In a broader sense, the invention provides a method for wireless linkage of a keypad to an induction type RFID reader.
Patent AU-708705-B2 (AU)
Title: Method of making an aluminum alloy brazing agent containing a flux
Inventor: OSAME YASUHIRO
IPC: B23K35/02
Filed: 1995-05-31
Granted: 1999-08-12
Abstract: An aluminum alloy brazing agent containing a flux is made by compacting a powder mixture of a matrix powder and a flux powder at a first temperature so as to form a rigid piece, and then conducting a secondary forming of the rigid piece into a desired shape at a second temperature. The first temperature is lower than 480  DEG C, preferably lower than 400  DEG C, and more preferably room temperature, so that the compacting may be conducted in the air. The second temperature is 300 - 575  DEG C for the secondary forming, which also may preferably be conducted in an non-oxidizing atmosphere, so that the brazing agent can be of an improved capability of brazing aluminum articles and be produced inexpensively.
Patent AU-618549-B2 (AU)
Title: Pharmaceutically useful polymorphic modification of buspirone
Inventor: SIMMS JACK C
IPC: C07D401/14
Filed: 1988-08-18
Granted: 1992-01-02
Abstract: The invention relates to the lower melting polymorphic crystalline form of buspirone hydrochloride which has a melting point of about 188  DEG C. It is useful for treating anxiety in a patient in need of such treatment.
Patent AU-780800-B2 (AU)
Title: Optical disc, recording apparatus and method for optical disc, and its reproducing method
Inventor: SAKO YOICHIRO
IPC: G11B7/2585
Filed: 2001-12-12
Granted: 2005-04-21
Abstract: The present invention provides an optical disc recording method of irradiating an optical beam to an optical disc including a basal plate made of synthetic resin which has a concavo-convex pattern formed in advance on one surface thereof, and a reflective coat made of metal which is formed over the concavo-convex pattern on the basal plate, to physically change the concavo-convex pattern so as to record identification data. <IMAGE>
Patent AU-672365-B2 (AU)
Title: A process for making morphine-6-glucuronide or substituted morphine-6-glucuronide
Inventor: SCHEINMANN FEODOR
IPC: C07D489/00
Filed: 1992-08-04
Granted: 1996-10-03
Abstract: uted morphine-6-glucuronide of formulae (I) is made by conjugation of a glucuronate ester and/or substituted glucuronate ester with morphine or substituted morphine in the presence of a Lewis acid catalyst and in the absence of silver catalysts and barium hydroxide and other heavy metal derivatives.
Patent AU-611491-B2 (AU)
Title: Aqueous silicone emulsion capable of crosslinking to form an elastomer on removal of water
Inventor: POUCHOL JEAN-MARIE
IPC: C08K3/38
Filed: 1988-10-18
Granted: 1991-06-13
Abstract: Thixotropic silicone emulsions crosslinkable into elastomeric state upon removal of water therefrom, e.g., to fabricate elastomer seals for the construction industry, have a pH of from 4 to 8 and a solids content of at least 50%, and contain: (A) 100 parts of an oil-in-water emulsion of an  alpha , omega -(dihydroxy)polydiorganosiloxane, and a stabilizing amount of at least one anionic or nonionic surface-active agent, or mixture thereof; (B) 1 to 15 parts of a siliceous reinforcing filler in powder form; (C) 0 to 250 parts of an inorganic filler other than the siliceous filler (B); (D) 0.01 to 2 parts of a catalytic tin compound; and (E) 0.1 to 5 parts of boric oxide, a boric acid or a borate.
Patent AU-678717-B2 (AU)
Title: Integrated end stops for zipper slider
Inventor: MORGAN KEVIN P
IPC: G01R33/09
Filed: 1995-05-04
Granted: 1997-06-05
Abstract: A leakproof plastic zipper with integrated end stops for a zipper slider particularly suited for thermoplastic bags. An increased flange height above the interlocking elements of the zipper and an increased plow depth on the separator of the slider extending down between the flanges provide a means of stopping the travel of the slider past the ends of the zipper. The separator structure depending from the slider has a configuration in vertical cross-section corresponding to an inverted T, the horizontal portion of the T having the ends thereof adapted to be received in window structure in the flanges above the interlocking elements and adjacent one of the integrated end stops.
Patent AU-771457-B2 (AU)
Title: Transmit diversity method and system
Inventor: HOTTINEN ARI
IPC: H04B7/06
Filed: 2000-02-11
Granted: 2004-03-25
Abstract: The invention relates to a transmit diversity method for a wireless communication system comprising a transmitting element and at least one receiver, wherein a transmission signal is transmitted from the transmitting element to the at least one receiver in accordance with a weight information determined in response to a feedback information. The feedback information is derived from the response at the at least one receiver to the transmission signal, and is fed back using multiplexed feedback signals. Multiple feedback signal quantization constellations and/or constellation specific feedback subchannels can be used for channel probing, such that the total feedback resolution and robustness can be enhanced, while maintaining low signaling capacity of the feedback channel.
Patent AU-611507-B2 (AU)
Title: Laminated metal sheet
Inventor: HEYES PETER JOHN
IPC: B32B15/08
Filed: 1988-10-12
Granted: 1991-06-13
Abstract: A laminated metal sheet, the metal sheet having adhered on at least one of its major surfaces a composite film comprising: an inner layer of a thermoplastic polymer incorporating a white pigment and a toner for compensating for the natural colour of the metal sheet, and an outer layer of a thermoplastic polymer incorporating a white pigment, the concentration of white pigment in layer (B1) being lower than the concentration of white pigment in layer (A1). The laminated metal sheet of the invention is useful for forming into containers or various components thereof.
Patent AU-763824-B2 (AU)
Title: Vanilloid analogues containing resiniferatoxin pharmacophores as potent vanilloid receptor agonists and analgesics, compositions and uses thereof
Inventor: LEE JEEWOO
IPC: C07C235/34
Filed: 2000-02-21
Granted: 2003-07-31
Abstract: The present invention is related to new vanilloid analogues containing resiniferatoxin pharmacophores, pharmaceutical compositions comprising such analogues, and their uses as vanilloid receptor agonists and potent analgesics. The present invention provides a pharmaceutical composition for treating acute, chronic, inflammatory or neuropathic pains or for treating bladder hypersensitivity.
Patent AU-749209-B2 (AU)
Title: Electronic program guide with related-program search feature
Inventor: HERRINGTON W BENJAMIN
IPC: H04H20/00
Filed: 1999-11-30
Granted: 2002-06-20
Abstract: A system for searching for programs is provided. The system may be provide the user with an opportunity to indicate an interest in a given program. The system may provide the user with an opportunity to request that the system locate programs that are related to the given program in which the user has indicated an interest. The system may locate program listings that are related to the given program. The located program listings may be related to the given program based on attributes of the given program. The system may display a list of located listings and allow the user to select listings from the list. The system may tune to a program selected from the list, may display an information display screen for a program selected from the list, etc. The system may provide the user with an opportunity to configure and save search parameters. The system may sort related program listings based on the attributes of the given program. The system may provide the user with the opportunity to retrieve saved searches to locate currently available program listings and the opportunity to delete a saved search, rename a saved search, receive automatic notifications of programs matching a saved search, etc.
Patent AU-612217-B2 (AU)
Title: Polysiloxazanes, a process for their preparation, and their use as precursors of ceramics and the said ceramics
Inventor: COLOMBIER CHRISTIAN
IPC: C08G77/54
Filed: 1988-12-23
Granted: 1991-07-04
Abstract: New polymers containing a plurality of -NR-Si- units and oxygen. 
<??>The invention also relates to a process for the preparation of these polysiloxazanes by reacting a halosilane with a hydrazine and water. 
<??>The polysiloxazanes obtained can be shaped and pyrolysed to ceramics.
Patent AU-652294-B2 (AU)
Title: Hip prosthesis stem with a medullary cavity drainage system
Inventor: SCHMIDT JOACHIM
IPC: A61F2/32
Filed: 1992-10-24
Granted: 1994-08-18
Abstract: The invention relates to a hip prosthesis stem which can be cemented in the medullary cavity of the femoral shaft. A prosthesis device is provided for the replacement of a femoral head by implantation into the femoral bone, said prosthetic device comprising: a) a stem of said prosthesis with a central borehole in its longitudinal direction, which can be curvilinear, following the curvature of the bone cavity, b) a drainage tube, to which vacuum can be applied, fitting slidably into said central borehole, c) a porous medullary cavity stopper fitting into the lower portion of the medullary cavity, d) a detachable fastening means between said drainage tube and said porous medullary cavity stopper, allowing said vacuum to act through said porous medullary stopper, and allowing to fasten the distal end of the drainage tube to the central portion of the medullary stopper. The invention further relates to a prosthesis for repair or replacement of a femoral head.
Patent AU-750461-B2 (AU)
Title: Multi-component system for the enzyme-catalysed oxidation of substrates and method for carrying out enzyme-catalysed oxidation
Inventor: CANDUSSIO ANTON
IPC: C11D3/386
Filed: 2000-02-17
Granted: 2002-07-18
Abstract: The invention relates to a multi-component system for carrying out mediator-dependent enzymatic oxidation, comprising an oxidation catalyst, an oxidant and a mediator and characterised in that a) the oxidation catalyst is chosen from the group comprising manganese oxidases; b) the oxidant is selected from the group comprising oxygen and oxygen-containing compounds; c) the mediator is selected from the group comprising compounds containing Mn ions.
Patent AU-569106-B2 (AU)
Title: Fluid dispensing apparatus
Inventor: GIBSON JAMES DONALD MACKAY
IPC: A41D1/10
Filed: 1984-08-22
Granted: 1988-01-21
Abstract: An apparatus for the application of crease setting composition comprises at least one movable arm 12 capable of insertion into a leg of a pair of trousers to be creased, the arm carrying at, or near, one end thereof an applicator head 20 comprising a nozzle 22 for the application of crease setting composition and guide means 24 for locating the nozzle within the crease to be treated. Means are provided, for example, a pump or compressed air, for urging crease setting composition through the nozzle into the crease to be set in timed relationship with the relative movement between the applicator head 20 and the trousers 34. A method of operation is also disclosed.
Patent AU-671611-B2 (AU)
Title: Human kunitz-type protease inhibitor variants
Inventor: BJORN SOREN ERIK
IPC: C12N15/09
Filed: 1993-01-07
Granted: 1996-09-05
Abstract: A variant of the C-terminal Kunitz-type protease inhibitor domain of the  alpha 3 chain of human type VI collagen, the variant comprising the following amino acid sequence X1 X16 Asp Ile Cys Lys Leu Pro Lys Asp X2 Gly X3 Cys X4 X5 X6 X7 X8 X9 Trp Tyr Tyr Asp Pro Asn Thr Lys Ser Cys Ala Arg Phe X10 Tyr Gly Gly Cys X11 X12 X13 Glu Asn Lys Phe X14 Ser Gln Lys Glu Cys Glu Lys Val Cys Ala Pro X15 (SEQ ID NO. 1) wherein X1, X15, and X16 represents a naturally occurring amino acid residues except Cys and X2-X14 each independently respresents a naturally occurring amino acid residue, with the proviso that at least one of the amino acid residues X1-X16 is different from the corresponding amino acid residue of the native sequence. Alternatively, the N-terminal Asp may be preceded by H or 3-5 amino acid residues and the C-terminal Pro may be followed by OH or 3-5 amino acid residues.
Patent AU-567593-B2 (AU)
Title: Polysaccharide - haemoglobin compound
Inventor: WONG JEFFREY TZE-FEI
IPC: C08H1/00
Filed: 1984-10-26
Granted: 1987-11-26
Abstract: There is described a water soluble compound having a molecular weight of from about 70,000 to about 2,000,000, and having the formula 1,where PS represents a physiologically acceptable polysaccharide of molecular weight from about 2,000 to about 2,000,000,X represents a covalently bonded chemical bridging group,HB represents a haemoglobin residue, andZ represents an oxygen affinity reducing ligand, containing 2 or more phosphate groups.There is also described haemoglobin linked to an oxygen affinity reducing ligand derived from inositol phosphate, and polymers of such linked haemoglobin.Processes for making the compounds, and their formulation and use as oxygen transporting agents, are also described.
Patent AU-618811-B2 (AU)
Title: Glazing panel for motor vehicles
Inventor: KUNERT HEINZ
IPC: B29C48/16
Filed: 1989-05-26
Granted: 1992-01-09
Abstract: Production of a glazing, ready to be installed, and intended to be bonded to the frame of a vehicle body void. 
<??>According to the invention there are deposited, on the pane of glass (1), or on an opaque lining (10) in the form of a frame adhering to the pane (1), two partial beads of adhesive (18), simultaneously or one immediately behind the other. The adhesive mass forming the first profiled bead (18) is selected or treated in such a way that this partial bead sets in a comparatively short time. The adhesive mass forming the other partial profiled bead (15) is selected or treated in such a way that this bead (15) remains plastically deformable and adhering for long enough to be used directly in bonding the glazing to the void during its mounting. The bead of adhesive (18), which sets in a short time, can be used if required to attach parts of the structural frame, for example a tearing thread (21), and advantageously comprises a shaped sealing lip (20). 
<IMAGE>
Patent AU-565840-B2 (AU)
Title: Amino acid solutions
Inventor: RIGO JACQUES
IPC: A23L1/305
Filed: 1984-12-19
Granted: 1987-10-01
Abstract: For the contracting States : BE CH DE FR GB IT LI LU NL SE 1. Amino acid solutions for children of low birth-weight, newborn babies at term and young infants, which solutions can be used orally, enterally or parenterally, and are characterized in that they contain essential amino acids, (thr, leu, ileu, val, met, phe, try, lys, his) and semi-essential amino acids (cys, tau, tyr) in a weight ratio between the essential and semi-essential amino acids and the total amino acids of 46 % to 63 % and in that they contain taurine in a quantity of 0.5 % to 0.7 % by weight relative to the total amino acids. For the contracting State : AT Process for the preparation of amino acid solutions for children of low birth-weight, newborn babies at term and young infants, which solutions can be used orally, enterally or parenterally, and is characterized in that several amino acids are mixed in such a way as to obtain solutions which contain essential amino acids (thr, leu, ileu, val, met, phe, try, lys, his) and semi-essential amino acids, in a weight ratio between the essential and semi-essential amino acids and the total amino acids of 46 % to 63 % and of taurine in a quantity of 0.5 % to 0.7 % by weight relative to the total amino acids.
Patent AU-673671-B2 (AU)
Title: Device and method to separate the components in mixtures of non-miscible liquids
Inventor: TORINI ALBERTO
IPC: C02F1/40
Filed: 1993-04-30
Granted: 1996-11-21
Abstract: PCT No. PCT/EP93/01053 Sec. 371 Date Mar. 23, 1995 Sec. 102(e) Date Mar. 23, 1995 PCT Filed Apr. 30, 1993 PCT Pub. No. WO93/22023 PCT Pub. Date Nov. 11, 1993The device (1) separates two components of a mixture (11) of non-miscible liquids, especially water or salt water and oils. The device (1) consists of a hollow body (2), having an inlet port (4) to feed the mixture (11) and outlet ports (5,6) to discharge the separated components, and a filter (7) formed of a loosely packed hydrophilic material (8) in fibers, and positioned between the inlet port (4) and the outlet port (5) of the separated water. The filter (7), when soaked with clean water, lets through only the water component of the mixture (11), while the oil component is repelled therefrom. The method separates the components of a mixture of non-miscible liquids, making use of the device specified heretofore.
Patent AU-593770-B2 (AU)
Title: Adhesin antigens, antibodies and DNA fragment encoding the antigen, methods and means for diagnosis and immunization etc
Inventor: LINDBERG FREDERIK CARL PETER
IPC: C12P21/08
Filed: 1985-05-02
Granted: 1990-02-22
Abstract: An antigen which, as its major immunizing component, comprises a determinant of an adhesin polypeptide or an immunogenically active subsequence thereof or a precursor therefor which is convertible to an immunogenically active form, antibodies against which determinant react with the adhesin polypeptide produced by pathogenic adhesin-forming bacteria which adhere to mammalian tissue, antibodies against such antigen, and DNA expressing, as a principal gene product thereof, such antigen.
Patent AU-758583-B2 (AU)
Title: Ligand binding assay and kit with a separation zone for disturbing analytes
Inventor: CARLSSON JAN
IPC: G01N33/543
Filed: 1999-04-30
Granted: 2003-03-27
Abstract: The invention relates to a method for determining the binding capability of a structure (ligand) to an analyte, which method comprises:  i. applying the sample to an application zone for sample (ASZ) on a flow matrix in which transport of components present in the sample may take place (transport flow), the flow matrix further comprising:  a) optionally an application zone (AR*Z) for a binding reactant (Reactant* = R*) which is analytically detectable, b) a detection zone (DZ) which is located downstream of ASZ and comprises another binding reactant (Capturer) firmly anchored to the matrix and in which a complex (signal complex) containing the Capturer and the analyte and/or Reactant* is formed during the method, and  ii. detecting the signal complex in the detection zone, the measured signal being used for determining the analyte,  wherein the flow matrix comprises at least one separation zone (SZ) between ASZ and DZ and this zone (SZ) exhibits a structure (ligand) having binding capability for the analyte, and the binding capability of the ligand for the analyte is determined. According to the invention, the flow matrix comprises at least one separation zone (SZ) between ASZ and DZ, which zone exhibits a structure (ligand) having binding capability for the analyte that is transported in the matrix. The invention also relates to a test kit comprising the flow matrix. <IMAGE>
Patent AU-670109-B2 (AU)
Title: A method and an equipment for installing a medicine capsule on a support
Inventor: HELLE TIMO
IPC: A61J3/00
Filed: 1993-07-14
Granted: 1996-07-04
Abstract: The invention relates to a method and an equipment for inserting a tubular medicinal capsule on a support. In accordance with the invention, the opening extending through the capsule is expanded by blowing pressurized air into the opening immediately ahead the support being inserted into the opening. After the capsule has entered into its position, the pressurization is relieved, whereby the capsule opening contracts and locks the capsule on the support.
Patent AU-710817-B2 (AU)
Title: Anionic latex composition having surface hydrophilicity
Inventor: NODA ISAO
IPC: A61F13/49
Filed: 1995-12-13
Granted: 1999-09-30
Abstract: The present invention is directed to a latex composition comprising: a liquid phase selected from water, water-miscible solvents, or mixtures thereof; and from about 5 to about 50 % by weight of latex particles dispersed in the aqueous phase. The latex particles comprise an elastomeric hydrophobic core and an outer hydrophilic shell attached to the core. The core comprises a polymer comprising one or more elastomer forming monomeric units and one or more carboxylate containing monomeric units. The shell comprises moieties L-X, wherein L comprises a hydrophobic hydrocarbyl group containing one or more unsaturated bonds and X is a hydrophilic group. The present invention is also directed to a process for making such a latex composition. The present invention is also directed to a paper sheet and an absorbent structure (e.g., a disposable diaper) comprising such a latex composition.